AGCT1532: Phase 3 Accelerated BEP Trial: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours

Medicine and Dentistry

1. Patient 100%
2. Germinoma 100%
3. Chemotherapy 100%
4. Etoposide 100%
5. Cisplatin 100%
6. Bleomycin 100%
7. Therapeutic Procedure 83%
8. Arm 50%
9. Death 33%
10. First-Line Chemotherapy 16%
11. Association 16%
12. Biological Marker 16%
13. Health 16%
14. Disease Exacerbation 16%
15. Overall Survival 16%
16. Progression Free Survival 16%
17. Quality of Life 16%
18. Adverse Event 16%
19. Cells 16%